EMFOSIK-10
March 28, 2026
EMFOSIK-M 12.5/500
March 28, 2026
EMFOSIK-25
₹4,100.00
Composition:
Empagliflozin 25 mg
Packaging Detail:
10 x 10
Description
A higher-strength tablet of Empagliflozin, an SGLT2 inhibitor. It provides more potent glucose-lowering effects and cardiovascular protection for patients with type 2 diabetes who require stronger glycemic control.
Indications
Indications
-
Type 2 diabetes mellitus requiring stronger glycemic control.
-
To reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
-
Heart failure with reduced ejection fraction.
Side Effects
Side Effects
-
Genital fungal infections.
-
Urinary tract infections.
-
Increased urination and thirst.
-
Dehydration and dizziness.
-
Rare risk of ketoacidosis.
Reviews 0
Related products
-
ACEFOX-P
₹560.00 -
AZIMEL-500
₹79.19 -
CEFIMOX-O
₹1,900.00
Reviews
There are no reviews yet.